ACXP | Acurx Pharmaceuticals, Inc. Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019
Revenue	-	-	-	-	-
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expenses	14.57 Million	12.09 Million	12.81 Million	4.6 Million	5.93 Million
Selling, General and Administrative Expenses	8.53 Million	7.33 Million	10.78 Million	2.39 Million	2.42 Million
Research and Development Expenses	6.04 Million	4.75 Million	2.03 Million	2.2 Million	3.51 Million
Other Expenses	-	-	-	-	-
Cost and Expenses	14.57 Million	12.09 Million	12.81 Million	4.6 Million	5.93 Million
Operating Income	-14.57 Million	-12.09 Million	-12.88 Million	-4.6 Million	-5.93 Million
Interest Expense	-	-	-	-	-
Income Tax Expense	-	-1224.00	-66.5 Thousand	-4598.04	-5934.25
Earnings before Tax	-14.57 Million	-12.09 Million	-12.74 Million	-4.6 Million	-5.93 Million
Net Income	-14.57 Million	-12.09 Million	-12.68 Million	-4.6 Million	-5.93 Million
Earnings Per Share Basic	-1.15	-1.12	-1.24	-0.46	-0.60
Earnings Per Share Diluted	-1.15	-1.12	-1.24	-0.46	-0.60
Weighted Average Shares Outstanding	12.67 Million	10.81 Million	10.21 Million	9.91 Million	9.91 Million
Weighted Average Shares Outstanding (Diluted)	12.67 Million	10.81 Million	10.21 Million	9.91 Million	9.91 Million
Gross Margin	-	-	-	-	-
EBIT Margin	-	-	-	-	-
Profit Margin	-	-	-	-	-
EBITDA	-	-12.09 Million	-	-4.6 Million	-5.93 Million
Earnings Before Tax Margin	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	4.12 Million	4.37 Million	5.11 Million	14.57 Million	3.11 Million	3.44 Million
Selling, General and Administrative Expenses	2.29 Million	2.82 Million	3.17 Million	-	1.76 Million	1.7 Million
Research and Development Expenses	1.82 Million	1.55 Million	1.94 Million	-	1.34 Million	1.73 Million
Other Expenses	-	-	-	-	-	-
Cost and Expenses	4.12 Million	4.37 Million	5.11 Million	14.57 Million	3.11 Million	3.44 Million
Operating Income	-4.12 Million	-4.37 Million	-5.11 Million	-14.57 Million	-3.11 Million	-3.44 Billion
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-4.12 Million	-4.37 Million	-5114.59	-14.57 Thousand	-3115.98	3.44 Billion
Earnings before Tax	-4.12 Million	-4.37 Million	-5.11 Million	-14.57 Million	-3.11 Million	-3.44 Million
Net Income	-4.12 Million	-4.37 Million	-5.11 Million	-14.57 Million	-3.11 Million	-3.44 Million
Earnings Per Share Basic	-0.26	-0.28	-0.38	-	-0.24	-0.28
Earnings Per Share Diluted	-0.26	-0.28	-0.38	-	-0.24	-0.28
Weighted Average Shares Outstanding	15.82 Million	15.47 Million	13.46 Million	12.67 Million	13 Million	12.18 Million
Weighted Average Shares Outstanding (Diluted)	15.82 Million	15.47 Million	13.46 Million	12.67 Million	13 Million	12.18 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-4.12 Million	-4.37 Million	-5.11 Million	-	-3.11 Million	-3.44 Million
Earnings Before Tax Margin	-	-	-	-	-	-